Perhaps this is what President Trump is exploring. Reuters reports: Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid by other developed countries, according to two company sources who called the option the pharmaceutical industry’s top concern.Both sources, who were not authorized to speak publicly, said…
Nourish’s Series B round was led by J.P. Morgan Private Capital’s Growth Equity Partners. In total, the company has raised $115 million. The post Nourish Lands $70M to Fight Chronic Disease with Nutrition Care appeared first on MedCity News.
Contraline released promising new trial data showing that its male contraceptive gel has demonstrated safety and efficacy in the first two trial participants to reach the two-year mark. The company is aiming to earn the product’s FDA approval by the end of 2028, according to CEO Kevin Eisenfrats. The post Trial Data Shows ‘IUD for…
This factsheet discusses breast cancer screening and prevention services, and reviews the scope of private and public insurance coverage, as well as access to those services for women in the US.
At Spring NAACOS meeting, Ascension’s Pranali Trivedi spoke about how their electronic clinical quality measure strategy goes beyond the MSSP
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
Etiome’s precision medicine approach introduces a temporal component to treating disease — drugs developed specifically to treat disease at particular points in time even before symptoms show. The Flagship Pioneering startup’s approach offers the potential to prevent disease; in cases where disease is already present, Etiome aims to halt or even reverse it. The post…
Ben Zeskind, co-founder, president and CEO of Immuneering, is attempting a new approach to treat certain types of cancers. If it works, there will be a vast improvement in the quality of life of cancer patients. The post MedCity Pivot: What if Pancreatic Cancer Became a Chronic Disease? appeared first on MedCity News.
Speaking at a NAACOS meeting, Deborah McGill of MaineHealth Medical Group said tech tools have been great enablers of change
The time to innovate is now. By embracing transformative solutions, insurers and employers can not only address systemic challenges but also create a future where healthcare is equitable and sustainable. The post How Health Insurers Are Embracing Technology to Serve Real People appeared first on MedCity News.